The economic burden of localized prostate cancer and insights derived from cost-effectiveness studies of the different treatments

Prostate cancer is one of the most frequent and impacting malignant neoplasms for men. In particular, localized prostate cancer has a notably high incidence and prevalence, despite which a solid consensus on treatment and procedure of care has not yet been reached. This article aims to shed light on...

Descripción completa

Detalles Bibliográficos
Autores: Cantarero Prieto, David|||0000-0001-8082-0639, Lera Torres, Javier Isaac|||0000-0002-0367-265X, Lanza León, Paloma|||0000-0002-0369-180X, Barreda Gutiérrez, Marina|||0000-0002-5952-6758, Guillem Porta, Vicente, Castelo Branco, Luis, Martín Moreno, José María
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad de Cantabria (UC)
Repositorio:UCrea Repositorio Abierto de la Universidad de Cantabria
Idioma:inglés
OAI Identifier:oai:repositorio.unican.es:10902/28278
Acceso en línea:https://hdl.handle.net/10902/28278
Access Level:acceso abierto
Palabra clave:Economic burden
Cost of illness
Cost-effectiveness analysis
Localized prostate cancer
Descripción
Sumario:Prostate cancer is one of the most frequent and impacting malignant neoplasms for men. In particular, localized prostate cancer has a notably high incidence and prevalence, despite which a solid consensus on treatment and procedure of care has not yet been reached. This article aims to shed light on this challenge by characterizing the economic burden and cost-effectiveness of different treatment strategies for localized prostate cancer after analyzing published comparable data from studies conducted in OECD countries.

Similares en LA Referencia